Aurinia Pharmaceuticals AUPH Accounts Payable

Accounts Payable at other companies

Rogers CorporationROG

$63.1M+18.2%

Vera TherapeuticsVERA

$13.91M+50.2%

ANI PharmaceuticalsANIP

$73.83M+35.3%

Theravance BiopharmaTBPH

$1.1M-54.3%

Opko HealthOPK

$50.04M-11.7%

LQD

Liquidia CorporationLQDA

$10.98M+26.6%

FAQ

What is Aurinia Pharmaceuticals's accounts payable?

Aurinia Pharmaceuticals (AUPH) reported accounts payable of $1.74M in Q2 2026.

How has Aurinia Pharmaceuticals's accounts payable changed year-over-year?

Aurinia Pharmaceuticals's accounts payable decreased by 47.6% year-over-year, from $3.31M to $1.74M.

What is the long-term trend for Aurinia Pharmaceuticals's accounts payable?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accounts payable has grown at a 4.7% compound annual growth rate (CAGR), from $2.64M to $3.31M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.